Clinical Trial Update: Percutaneous Neurostimulation to Treat Paroxysmal Sympathetic Hyperactivity in Children [NA]

View source ↗

Summary

A clinical trial evaluating percutaneous neurostimulation to treat paroxysmal sympathetic hyperactivity in children has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Sympathetic Hyperactivity

Drugs mentioned

• Percutaneous neurostimulation device

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Paroxysmal Sympathetic Hyperactivity | NA | Status: TERMINATED